Repligen (RGEN) Net Income Growth (3y) (2013 - 2026)
Repligen (RGEN) Net Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 24.56% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 2.79% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 19.70% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -0.49% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -64.60% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -58.17% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 8.69% |
| 10 | Repligen | 7.37 Bn | 6.39 Bn | 108.28 Mn | -18.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.31% |
| Dec 31, 2025 | -45.41% |
| Sep 30, 2025 | -28.27% |
| Jun 30, 2025 | -33.19% |
| Mar 31, 2025 | -50.10% |
| Dec 31, 2024 | -61.90% |
| Sep 30, 2024 | -26.40% |
| Jun 30, 2024 | -45.98% |
| Mar 31, 2024 | -51.81% |
| Dec 31, 2023 | -30.35% |
| Sep 30, 2023 | 5.16% |
| Jun 30, 2023 | 7.68% |
| Mar 31, 2023 | 16.09% |
| Dec 31, 2022 | 100.86% |
| Sep 30, 2022 | 189.87% |
| Jun 30, 2022 | 83.31% |
| Mar 31, 2022 | 79.96% |
| Dec 31, 2021 | 57.71% |
| Sep 30, 2021 | 91.18% |
| Jun 30, 2021 | 136.53% |